NASDAQ: RAPT

Company Deals

RAPT Therapeutics Secures Ex-China Rights to Jemincare Group’s Anti-IgE Antibody JYB1904

Fineline Cube Dec 24, 2024

US-based biopharmaceutical company RAPT Therapeutics Inc. (NASDAQ: RAPT) has announced that it has obtained the...

Policy / Regulatory

China’s CDE Announces 95th Batch of Reference Preparations for Public Comment

Policy / Regulatory

China Ministry of Finance Restricts EU-Imported Medical Devices in Government Procurement Over RMB45 Million

Company Drug

SCG Cell Therapy Obtains NMPA Approval for SCG101V in Chronic HBV Study

Company Medical Device

BGI Genomics Launches Mini Breast Cancer 76-Gene Detection System for Personalized Treatment